Company page

Cullinan Therapeutics, Inc.

Cullinan Therapeutics, Inc. (CGEM) is a public company based in the United States, focusing on innovative cancer therapies. With a market capitalization of approximately $1.09 billion, Cullinan is dedicated to advancing its pipeline of treatments to improve patient outcomes. The company is committed to addressing unmet medical needs in oncology through its research and development efforts.